Bristol-Myers Squibb’s [NYSE: BMY] Breyanzi Receives FDA Approval
Bristol-Myers Squibb [NYSE: BMY] declared that FDA has awarded permission to the Breyanzi of the firm for the therapy of adult sufferers with relapsed or refractory large B-cell lymphoma. Breyazni is a CAR T cell Therapy. This therapy is a ray of hope for the victims experiencing relapsed or refractory large B-cell lymphoma. The authorization […]
Northern Dynasty’s [NAK] Pebble Partnership Receives Grand Jury Subpoena
Northern Dynasty Minerals Ltd. [AMEX: NAK] disclosed that its wholly-owned Alaska-based US subsidiary Pebble Partnership Limited and the ex-CEO of Pebble, Tom Collier has received the Subpoena. The summon was delivered to the firm and CEO by the US Attorney’s Office for the District of Alaska. CEO and Pebble Limited has received the summon following […]
